Practices have been “really enthusiastic” about the MYAH device, Danielle Lee, clinical affairs specialist for Topcon, told OT at 100% Optical (25-27 February).
The MYAH offers topography with biometry, enabling clinicians to offer myopia management in practice and, Lee explained, “give clinicians the chance to monitor progression in patients and engage the patients and parents.”
With myopia control methods presenting a cost to patients and their families, Lee shared that it is helpful to be able to “quantify how much change we’re seeing,” while being able to observe how axial length starts to increase before the refractive error starts to change, “allows us to intervene earlier and potentially get better outcomes for patients.”
Changes in guidelines have helped to increase awareness of the device.
“It’s certainly a developing area. We launched the MYAH a few years ago and myopia management has grown exponentially in that time,” Lee explained.
“Particularly with COVID-19, we’ve seen children spending a lot more time indoors and on screens. All these factors we know impact on the development of myopia have been compounded over the last few years,” Lee told OT. “So, we’ve seen a real boost in practitioners wanting to take care of these patients, wanting to intervene earlier, and having a device like this allows them to not only do that intervention but then monitor how effective it is and potentially build and make those treatments better for their patients.”
The MYAH device also includes a suite of dry eye assessments: tear break-up time, non-invasive tear break up time, blink analysis, tear meniscus height and meibomian gland imaging.
“That all pulls out to a dry eye report, which can help increase compliance,” Lee shared. “We know that not everyone is particularly compliant with their dry eye treatment, so being able to give figures can really help with that as well.”
Comments (0)
You must be logged in to join the discussion. Log in